LPCN
Lipocine Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.44
−1.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.55x
- Price / sales
- 7.56x
- Price / cash flow
- -1.06x
Enterprise value
- Enterprise value
- -$11.4M
- EV / sales
- -7.26x
- EV / EBITDA
- 0.97x
- EV / EBIT
- 0.91x
- Market cap
- $11.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026